What is Motorika?
Motorika operates at the intersection of medical robotics and physical therapy, specializing in the development of sophisticated platforms designed to restore mobility and independence. The company's core portfolio includes the ReoGo system, which targets upper extremity rehabilitation, and the ReoAmbulator, a specialized platform for lower limb recovery. With a robust intellectual property portfolio comprising over 30 patents, Motorika has successfully integrated its technology into hundreds of clinical and hospital environments. Currently, the firm maintains a commercial presence in 33 countries, including key markets in the United States, Europe, and China, having facilitated over one million patient therapy sessions to date.
How much funding has Motorika raised?
Motorika has raised a total of $19.5M across 1 funding round:
Unspecified
$19.5M
Unspecified (2009): $19.5M, investors not publicly disclosed
Key Investors in Motorika
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Motorika?
With this recent capital, Motorika is positioned to transition into a new phase of enterprise-level expansion. The strategic roadmap likely involves deepening its penetration in high-growth international markets and potentially diversifying its robotic rehabilitation suite to address emerging clinical needs. As the demand for automated, data-driven physical therapy continues to rise, Motorika is well-equipped to leverage its existing infrastructure to enhance patient outcomes. Future growth will likely focus on optimizing clinical workflows and expanding the reach of its robotic platforms to underserved regions, thereby cementing its status as a leader in the medical technology sector.
See full Motorika company page
